(Q53335014)

13 May 2018

title

Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis. (English)

1 reference

13 May 2018

author

John R. Falck

7

1 reference

13 May 2018

author name string

Ambra Pozzi

1

1 reference

13 May 2018

Maria Raquel Ibanez

2

1 reference

13 May 2018

Arnaldo E Gatica

3

1 reference

13 May 2018

Shilin Yang

4

1 reference

13 May 2018

Shouzuo Wei

5

1 reference

13 May 2018

Shaojun Mei

6

1 reference

13 May 2018

Jorge H Capdevila

8

1 reference

13 May 2018

language of work or name

English

0 references

publication date

3 April 2007

1 reference

13 May 2018

Journal of Biological Chemistry

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 May 2018

volume

282

1 reference

13 May 2018

issue

24

1 reference

13 May 2018

page(s)

17685-17695

1 reference

13 May 2018

Peroxisome Proliferator-Activated Receptors, Fatty Acid Oxidation, Steatohepatitis and Hepatocarcinogenesis

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator activated receptors and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

PPAR activators inhibit endothelial cell migration by targeting Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Fenofibrate inhibits angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator-activated receptor alpha target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Arachidonic acid epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Inhibition of melanoma metastases by fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferators activate growth regulatory pathways largely via peroxisome proliferator-activated receptor alpha-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Angiogenesis--a new target for future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

A review on pro- and anti-angiogenic factors as targets of clinical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Dietary fat, cholesterol and colorectal cancer in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701429200

21 January 2018

Identifiers

DOI

10.1074/JBC.M701429200

1 reference

13 May 2018

1 reference

13 May 2018